KP Tissue Inc
KP Tissue Inc., through its interest in Kruger Products Inc., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through the Consumer and Away-From-Home segments. It offers bathroom and facial tissues, paper towels, and napkins. The company markets its products under Cashmere, Purex, Scotties, SpongeTowels, Bonterr… Read more
KP Tissue Inc (KPTSF) - Net Assets
Latest net assets as of December 2025: $69.74 Million USD
Based on the latest financial reports, KP Tissue Inc (KPTSF) has net assets worth $69.74 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($71.54 Million) and total liabilities ($1.80 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $69.74 Million |
| % of Total Assets | 97.48% |
| Annual Growth Rate | -5.2% |
| 5-Year Change | -8.08% |
| 10-Year Change | -39.4% |
| Growth Volatility | 10.6 |
KP Tissue Inc - Net Assets Trend (2012–2025)
This chart illustrates how KP Tissue Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for KP Tissue Inc (2012–2025)
The table below shows the annual net assets of KP Tissue Inc from 2012 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $69.74 Million | +0.32% |
| 2024-12-31 | $69.52 Million | +1.70% |
| 2023-12-31 | $68.36 Million | -7.66% |
| 2022-12-31 | $74.03 Million | -2.42% |
| 2021-12-31 | $75.87 Million | +14.38% |
| 2020-12-31 | $66.33 Million | -13.99% |
| 2019-12-31 | $77.12 Million | -19.68% |
| 2018-12-31 | $96.02 Million | +1.96% |
| 2017-12-31 | $94.17 Million | -18.17% |
| 2016-12-31 | $115.08 Million | -8.09% |
| 2015-12-31 | $125.22 Million | -16.85% |
| 2014-12-31 | $150.59 Million | -4.67% |
| 2013-12-31 | $157.97 Million | +13.20% |
| 2012-12-31 | $139.55 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to KP Tissue Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 16012.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $22.98 Million | 32.95% |
| Other Comprehensive Income | $16.95 Million | 24.30% |
| Other Components | $144.70 Million | 207.48% |
| Total Equity | $69.74 Million | 100.00% |
KP Tissue Inc Competitors by Market Cap
The table below lists competitors of KP Tissue Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Orthex Oyj
HE:ORTHEX
|
$56.15 Million |
|
HydroGraph Clean Power Inc.
OTCQB:HGRAF
|
$56.16 Million |
|
K N Kenanga Holdings Bhd
KLSE:6483
|
$56.17 Million |
|
Dongbu
KO:005960
|
$56.18 Million |
|
C-Rad AB (publ)
ST:CRAD-B
|
$56.12 Million |
|
Southern Michigan Bancorp Inc
PINK:SOMC
|
$56.12 Million |
|
Hiap Teck Venture Bhd
KLSE:5072
|
$56.10 Million |
|
BEST Inc
NYSE:BEST
|
$56.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in KP Tissue Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 69,517,000 to 69,742,117, a change of 225,117 (0.3%).
- Other comprehensive income decreased equity by 1,658,826.
- Other factors increased equity by 1,883,943.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $0.00 | -0.0% |
| Other Comprehensive Income | $-1.66 Million | -2.38% |
| Other Changes | $1.88 Million | +2.7% |
| Total Change | $- | 0.32% |
Book Value vs Market Value Analysis
This analysis compares KP Tissue Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.81x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.32x to 0.81x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2012-12-31 | $17.45 | $5.64 | x |
| 2013-12-31 | $18.05 | $5.64 | x |
| 2014-12-31 | $17.05 | $5.64 | x |
| 2015-12-31 | $14.05 | $5.64 | x |
| 2016-12-31 | $12.73 | $5.64 | x |
| 2017-12-31 | $10.58 | $5.64 | x |
| 2018-12-31 | $10.30 | $5.64 | x |
| 2019-12-31 | $8.08 | $5.64 | x |
| 2020-12-31 | $6.84 | $5.64 | x |
| 2021-12-31 | $7.71 | $5.64 | x |
| 2022-12-31 | $7.45 | $5.64 | x |
| 2023-12-31 | $6.87 | $5.64 | x |
| 2024-12-31 | $6.97 | $5.64 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently KP Tissue Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.50%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.03x
- Recent ROE (3.50%) is above the historical average (-4.18%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2012 | 0.00% | 0.00% | 0.00x | 1.00x | $-13.96 Million |
| 2013 | -0.18% | -16.49% | 0.01x | 1.03x | $-16.08 Million |
| 2014 | -1.67% | 0.00% | -0.01x | 1.03x | $-17.58 Million |
| 2015 | -25.03% | 0.00% | -0.26x | 1.03x | $-43.87 Million |
| 2016 | -1.50% | -2570.15% | 0.00x | 1.04x | $-13.23 Million |
| 2017 | -5.61% | 0.00% | -0.03x | 1.01x | $-15.13 Million |
| 2018 | -0.18% | 0.00% | 0.00x | 1.06x | $-9.77 Million |
| 2019 | -8.47% | 0.00% | 0.00x | 1.08x | $-14.24 Million |
| 2020 | -2.94% | 0.00% | 0.00x | 1.08x | $-8.59 Million |
| 2021 | 1.63% | 0.00% | 0.00x | 1.06x | $-6.35 Million |
| 2022 | -13.84% | 0.00% | 0.00x | 1.10x | $-17.65 Million |
| 2023 | -0.01% | 0.00% | 0.00x | 1.03x | $-6.84 Million |
| 2024 | 3.50% | 0.00% | 0.00x | 1.03x | $-4.52 Million |
Industry Comparison
This section compares KP Tissue Inc's net assets metrics with peer companies in the Household & Personal Products industry.
Industry Context
- Industry: Household & Personal Products
- Average net assets among peers: $1,984,957,715
- Average return on equity (ROE) among peers: 1.63%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| KP Tissue Inc (KPTSF) | $69.74 Million | 0.00% | 0.03x | $56.14 Million |
| Acme United Corporation (ACU) | $25.35 Million | 10.15% | 0.96x | $128.30 Million |
| Beiersdorf Aktiengesellschaft (BDRFF) | $4.20 Billion | 15.71% | 0.65x | $11.93 Billion |
| Science to Consumers Inc (BEUT) | $-3.05K | 0.00% | 0.00x | $1.09K |
| Société BIC SA (BICEY) | $1.18 Billion | 11.18% | 0.32x | $566.61 Million |
| Blue Moon Group Holdings Limited (BLUMY) | $8.66 Billion | -8.65% | 0.19x | $1.01 Billion |
| Bemax Inc (BMXC) | $1.50K | -133.51% | 1.67x | $3.63K |
| Bruush Oral Care Inc. (BRSHF) | $-216.93K | 0.00% | 0.00x | $335.48 |
| Park Ha Biological Technology Co., Ltd. (BYAH) | $-578.18K | 0.00% | 0.00x | $11.76 Million |
| Church & Dwight Company Inc (CHD) | $3.86 Billion | 19.60% | 1.22x | $22.59 Billion |
| Colgate-Palmolive Company (CL) | $1.92 Billion | 101.83% | 4.19x | $66.02 Billion |